RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
RXRX on Nasdaq
Type / Class
Equity / Class A Common Stock, $0.00001 par value per share
Shares outstanding
4,564,846
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
324,107,219
Holdings value
$1,581,546,112
% of all portfolios
0.002%
Number of holders
318
Number of buys
174
Number of sells
-126
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 8.47% $185,021,391 32,346,397 ARK Investment Management LLC 31 Dec 2024
BlackRock, Inc. 6.1% $134,057,558 23,436,636 BlackRock, Inc. 31 Dec 2024
RA CAPITAL MANAGEMENT, L.P. 2% $44,187,549 7,725,096 RA Capital Management, L.P. 31 Dec 2024
Kim Yohan 5.86% $1,530,100 267,500 Yohan Kim 04 Apr 2025

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 324,107,219 $1,581,546,112 +$66,840,403 $4.88 318
2025 Q2 310,182,949 $1,569,493,304 +$26,510,398 $5.06 329
2025 Q1 304,244,163 $1,609,644,830 -$29,277,099 $5.29 330
2024 Q4 304,544,141 $2,058,776,356 +$268,240,445 $6.76 310
2024 Q3 264,392,743 $1,743,289,324 +$54,064,157 $6.59 262
2024 Q2 251,836,128 $1,888,574,788 +$298,622,706 $7.5 264
2024 Q1 212,714,397 $2,120,552,518 +$62,304,334 $9.97 242
2023 Q4 206,501,532 $2,035,976,922 +$306,507,294 $9.86 194
2023 Q3 152,228,034 $1,164,429,792 +$189,175,887 $7.65 189
2023 Q2 127,547,789 $952,749,699 +$12,757,431 $7.47 155
2023 Q1 126,153,704 $841,388,403 +$14,595,249 $6.67 157
2022 Q4 123,786,379 $954,397,559 +$134,707,594 $7.71 144
2022 Q3 113,749,582 $1,210,251,991 +$75,709,491 $10.64 141
2022 Q2 106,463,853 $861,094,172 +$96,496,440 $8.14 130
2022 Q1 95,043,699 $680,250,380 -$12,978,444 $7.16 124
2021 Q4 94,346,907 $1,616,473,942 +$295,962,917 $17.13 122
2021 Q3 54,909,739 $1,262,978,377 +$181,552,159 $23.01 82
2021 Q2 46,974,230 $1,714,334,294 +$1,714,333,294 $36.5 75
2021 Q1 30 $1,000 $33.33 1
2020 Q4 30 $1,000 $33.33 1
2020 Q3 30 $1,000 $33.33 1
2020 Q2 30 $1,000 $33.33 1
2020 Q1 30 $1,000 $33.33 1
2019 Q4 30 $1,000 $33.33 1
2019 Q3 30 $1,000 $33.33 1
2019 Q2 30 $1,000 $33.33 1
2019 Q1 30 $1,000 $33.33 1